CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Nov 04, 2024. (Total: 6390 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-18 (of 18 Records)

Query Trace: Welch SR[original query]
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling Lo MK , Jain S , Davies KA , Sorvillo TE , Welch SR , Coleman-McCray JD , Chatterjee P , Hotard AL , O'Neal T , Flint M , Ai H , Albariño CG , Spengler JR , Montgomery JM , Spiropoulou CF . Antiviral Res 2024 231 106013
Optimal reference genes for RNA tissue analysis in small animal models of hemorrhagic fever viruses Davies KA , Welch SR , Sorvillo TE , Coleman-McCray JD , Martin ML , Brignone JM , Montgomery JM , Spiropoulou CF , Spengler JR . Sci Rep 2023 13 (1) 19384
Meeting report: 35th international conference on antiviral research in Seattle, WA, USA - March 21-25, 2022. Spengler JR , Welch SR , Deval J , Gentry BG , Brancale A , Carter K , Moffat J , Meier C , Seley-Radtke KL , Schang LM . Antiviral Res 2022 211 105521
Mouse models of Ebola virus tolerance and lethality: Characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted variants Spengler JR , Welch SR , Ritter JM , Harmon JR , Coleman-McCray JD , Genzer SC , Nascimento Seixas J , Scholte FEM , Davies KA , Bradfute SB , Montgomery JM , Spiropoulou CF . Antiviral Res 2022 210 105496
Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease. Welch SR , Spengler JR , Harmon JR , Coleman-McCray JD , Scholte FEM , Genzer SC , Lo MK , Montgomery JM , Nichol ST , Spiropoulou CF . mBio 2022 13 (2) e0329421
Lassa virus replicon particle vaccine protects strain 13/N guinea pigs against challenge with geographically and genetically diverse viral strains. Spengler JR , Kainulainen MH , Welch SR , Coleman-McCray JAD , Harmon JR , Condrey JA , Scholte FEM , Nichol ST , Montgomery JM , Albariño CG , Spiropoulou CF . J Infect Dis 2022 226 (9) 1545-1550
Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo. Tilston-Lunel NL , Welch SR , Nambulli S , de Vries RD , Ho GW , Wentworth DE , Shabman R , Nichol ST , Spiropoulou CF , de Swart RL , Rennick LJ , Duprex WP . mSphere 2021 6 (5) e0053721
Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform. Welch SR , Spengler JR , Genzer SC , Chatterjee P , Flint M , Bergeron É , Montgomery JM , Nichol ST , Albariño CG , Spiropoulou CF . Viruses 2021 13 (7)
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein is Dispensable for Growth In Vitro and Disease in Ifnar -/- Mice. Welch SR , Scholte FEM , Spengler JR , Ritter JM , Coleman-McCray JD , Harmon JR , Nichol ST , Zaki SR , Spiropoulou CF , Bergeron E . Microorganisms 2020 8 (5)
Inhibition of Nipah Virus by Defective Interfering Particles. Welch SR , Tilston NL , Lo MK , Whitmer SLM , Harmon JR , Scholte FEM , Spengler JR , Duprex WP , Nichol ST , Spiropoulou CF . J Infect Dis 2020 221 S460-S470
Lassa virus circulating in Liberia: a retrospective genomic characterisation. Wiley MR , Fakoli L , Letizia AG , Welch SR , Ladner JT , Prieto K , Reyes D , Espy N , Chitty JA , Pratt CB , Di Paola N , Taweh F , Williams D , Saindon J , Davis WG , Patel K , Holland M , Negron D , Stroher U , Nichol ST , Sozhamannan S , Rollin PE , Dogba J , Nyenswah T , Bolay F , Albarino CG , Fallah M , Palacios G . Lancet Infect Dis 2019 19 (12) 1371-1378
Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection. Scholte FEM , Hua BL , Spengler JR , Dzimianski JV , Coleman-McCray JD , Welch SR , McMullan LK , Nichol ST , Pegan SD , Spiropoulou CF , Bergeron E . mBio 2019 10 (4)
Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles. Kainulainen MH , Spengler JR , Welch SR , Coleman-McCray JD , Harmon JR , Scholte FEM , Goldsmith CS , Nichol ST , Albarino CG , Spiropoulou CF . J Infect Dis 2019 220 (8) 1281-1289
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus. Flint M , Chatterjee P , Lin DL , McMullan LK , Shrivastava-Ranjan P , Bergeron E , Lo MK , Welch SR , Nichol ST , Tai AW , Spiropoulou CF . Nat Commun 2019 10 (1) 285
The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model. Welch SR , Scholte FEM , Albarino CG , Kainulainen MH , Coleman-McCray JD , Guerrero LW , Chakrabarti AK , Klena JD , Nichol ST , Spengler JR , Spiropoulou CF . Front Cell Infect Microbiol 2018 8 240
Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds. Welch SR , Chakrabarti AK , Wiggleton Guerrero L , Jenks HM , Lo MK , Nichol ST , Spiropoulou CF , Albarino CG . PLoS Negl Trop Dis 2018 12 (3) e0006326
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems. Welch SR , Guerrero LW , Chakrabarti AK , McMullan LK , Flint M , Bluemling GR , Painter GR , Nichol ST , Spiropoulou CF , Albarino CG . Antiviral Res 2016 136 9-18
Virus fitness differences observed between two naturally occurring isolates of Ebola virus Makona variant using a reverse genetics approach. Albarino CG , Guerrero LW , Chakrabarti AK , Kainulainen MH , Whitmer SL , Welch SR , Nichol ST . Virology 2016 496 237-243